Dawood's aide Motiwala to face extortion trial on Nov 12

Agencies
October 22, 2018

London, Oct 22: London's West Magistrate Court has observed that underworld don Dawood Ibrahim's key aide Jabir Motiwala will remain in custody on remand and will appear for a case management hearing on November 12. A three-day trial in his extradition case has been scheduled between February 25 and 27 next year.

The 51-year-old had been denied bail during previous hearings and did not make any further application for bail on Friday. Police did not produce him in court owing to security reasons, he appeared before the court via live video link from Wandsworth prison.

The hearing against the Pakistani national on Friday took place after Motiwala made probably his last effort at the London High Court for bail and increased the bail surety amount to 1.5 million pounds, but the judge refused the bail stating that there was "genuine" fear that he could easily obtain a travel document using his connections and influence to flee the country.

The judge said that it would not be safe to give him bail even with the huge amount of 1.5 million pounds on offer.

During a previous hearing on September 27 at the Westminster Magistrate's Court, District Judge Emma Arbuthnot had refused the bail after bail surety of 1 million pounds was offered. The judge had maintained that there was a flight risk - the same argument upheld by the High Court. The judge also gave weight to the argument of the prosecution that the Karachi businessman could get access to alternative travel papers easily.

"As there is no bail application, I am remanding you in custody until November 12," Judge Tan Ikram had said.

Jabir Motiwala is facing extradition to the United States on money-laundering and extortion charges. His defence lawyer, Toby Cadman of Guernica law firm, told the court that his client had made an application in court to have his name changed in the case documents to Jabir Siddiq. He also indicated that Motiwala's defence intends to depose a number of legal experts as witnesses in the case, with the key issues being "abuse of process and entrapment" by the authorities.

He was repeatedly denied bail at previous hearings, with his defence team even presenting a letter from the Pakistani High Commissioner among the many sureties that he would not jump bail and abscond.

At the last hearing, the Pakistan government had also vouched for Motiwala's "good character", which was termed as "pretty unusual and unequivocal support" by his counsel.

The US extradition request follows a Federal Bureau of Investigation (FBI) investigation dating back to 2005 and Motiwala was arrested by Scotland Yard from Hilton Metropole, Edgware Road, London hotel on August 17, having arrived in the UK on business on a 10-year visa.

Motiwala has been described in the UK court proceedings as a "senior member" and "top lieutenant" of D Company - an allegation he has vehemently denied.

The FBI alleged that Motiwala went to Atlantic City for two days in 2011 to meet two undercover FBI agents for an alleged narcotics and money-laundering deal, but the defence says that he got trapped into it and unlawful methods were used to entrap him.
The investigating agency further alleged that he was also involved in smuggling of Class-A drugs in quantity of four kilograms into the country and issued threats to extort money from the proceeds of drugs sales and separately used threats and intimidation to collect money and rents from various people for the criminal syndicate he allegedly worked for.

Motiwala has denied the allegations and his lawyer has told the court that his grandfather and father were pivotal in setting up Karachi Stock Exchange (KSE) and belonged to a respectable business family with the history of genuine business credentials.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 11,2020

Kabul, May 11: Four back-to-back roadside bombs exploded in a northern district of Afghanistan's capital Kabul on Monday, wounding four civilians including a child, police said. Kabul police spokesman Ferdaws Faramarz said a clearance team was at the site of the attacks.

Militants have carried out several roadside bombings and rocket attacks in Kabul and other parts of the country in recent weeks, but Monday's four consecutive explosions appeared to be the first coordinated effort for some months.

The Taliban has not carried out any large attacks in the city since they signed a landmark withdrawal deal with the US in February, meant to pave the way for peace in the country. No group has claimed the attacks. The explosions come as authorities are trying to impose a lockdown in the capital to curb the spread of coronavirus in the country.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 7,2020

Washington, Jul 7: The US House of Representatives Judiciary Committee will grill the CEOs of US tech giants Apple, Google, Facebook and Amazon during an antitrust hearing on July 27.

Apple's Tim Cook, Facebook's Mark Zuckerberg, Alphabet's Sundar Pichai and Amazon's Jeff Bezos will testify before the antitrust panel that is working on proposals to reform and regulate the digital market.

The hearing would mark the first time all four top executives testify together in front of Congress, virtually or in-person depending on the panel's call in the COVID-19 pandemic times.

"Since last June, the Subcommittee has been investigating the dominance of a small number of digital platforms and the adequacy of existing antitrust laws and enforcement," House Judiciary Committee Chairman Jerrold Nadler (D-NY) and Antitrust Subcommittee Chairman David Cicilline (D-RI) said in a statement on Monday.

"Given the central role these corporations play in the lives of the American people, it is critical that their CEOs are forthcoming. As we have said from the start, their testimony is essential for us to complete this investigation.”

The House Judiciary Committee announced its antitrust probe into the four tech giants in June last year.

Last month, the committee sent letters to technology giants Apple, Facebook, Amazon and Alphabet (Google's parent company), asking them to confirm if their chief executives will testify as part of the committee's tech competition investigation.

Committee chair David Cicilline said the documents that the investigators sought were "essential" to the probe and that requests like this were part of the "appropriate process" to obtain them.

"The only CEO who has expressed reservation about appearing, through a representative, has been Amazon," Cicilline said. "No one in this country is above the law ... nobody is above answering a congressional subpoena".

The lawmakers want the tech giants to furnish documents that have been produced in relation to other competition probes and internal communications.

The letters that the committee sent also posed questions related to possible harms to competition in the market.

In addition to the antitrust probe, Apple's App Store policies are also facing scrutiny from the US Department of Justice.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
April 5,2020

Washington, Apr 5: US President Donald Trump on Saturday said that he has requested Prime Minister Narendra Modi to supply Hydroxychloroquine tablets that can be used to treat COVID-19 patients.

"After call today with Indian Prime Minister Narendra Modi, India is giving serious consideration to releasing the hold it put on a US order for hydroxychloroquine," Trump announced at the White House Coronavirus task force briefing that he requested PM Narendra Modi for more Hydroxychloroquine tablets.

President Trump did not shy away from saying he too will take a tablet of hydroxychloroquine after announcing that he has requested Prime Minister during his telephonic conversation earlier today to lift a hold on the US order of the medicine.

"I may take it too, will have to talk to my doctors," he added.

"India makes a lot of it. They need a lot too for their billion-plus people. 

The hydroxychloroquine, the anti-malaria drug will be released through the Strategic National Stockpile for treatment," he said.

"I said I would appreciate if they would release the amounts that we ordered" of hydroxychloroquine, he said.

The Indian government has put on hold the export of anti-malarial drug hydroxychloroquine and its formulations.

Prime Minister Narendra Modi said on Twitter, "Had an extensive telephone conversation with President @realDonaldTrump. 

We had a good discussion, and agreed to deploy the full strength of the India-US partnership to fight COVID-19."

Prime Minister conveyed deep condolences for the loss of lives in the United States and his prayers for the early recovery of those still suffering from the disease.

As on Sunday, the United States has at least 301,902 cases of coronavirus according to Johns Hopkins University's tally. 

At least 8,175 people have died in the US from coronavirus.

There was a steep rise in the number of cases in the last 24 hours. At least 23,949 new cases were reported, and at least 1,023 new deaths in the US have been reported in the last 24 hours.

US Secretary of State Michael Pompeo had discussions with External Affairs Minister S Jaishankar about the importance of continued close cooperation between the United States and India to combat coronavirus by strengthening global pharmaceutical supply chains.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.